Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 20


Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder.

Kim SW, Dodd S, Berk L, Kulkarni J, de Castella A, Fitzgerald PB, Kim JM, Yoon JS, Berk M.

Psychiatry Investig. 2015 Jul;12(3):349-55. doi: 10.4306/pi.2015.12.3.349. Epub 2015 Jul 6.


Genetic and Clinical Factors Affecting Plasma Clozapine Concentration.

Olsson E, Edman G, Bertilsson L, Hukic DS, Lavebratt C, Eriksson SV, Ösby U.

Prim Care Companion CNS Disord. 2015 Feb 19;17(1). doi: 10.4088/PCC.14m01704. eCollection 2015.


Pharmacokinetic studies for proving bioequivalence of orally inhaled drug products-critical issues and concepts.

Thakkar K, Mhatre S, Jadhav M, Goswami S, Shah R.

Front Pharmacol. 2015 Jun 3;6:117. doi: 10.3389/fphar.2015.00117. eCollection 2015. No abstract available.


Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.

Le Vee M, Jouan E, Stieger B, Lecureur V, Fardel O.

PLoS One. 2015 Mar 24;10(3):e0121232. doi: 10.1371/journal.pone.0121232. eCollection 2015.


Effect of smoking on the pharmacokinetics of inhaled loxapine.

Takahashi LH, Huie K, Spyker DA, Fishman RS, Cassella JV.

Ther Drug Monit. 2014 Oct;36(5):618-23. doi: 10.1097/FTD.0000000000000048.


Factors affecting the development of adverse drug reactions (Review article).

Alomar MJ.

Saudi Pharm J. 2014 Apr;22(2):83-94. doi: 10.1016/j.jsps.2013.02.003. Epub 2013 Feb 24. Review.


Multiple risk-behavior profiles of smokers with serious mental illness and motivation for change.

Prochaska JJ, Fromont SC, Delucchi K, Young-Wolff KC, Benowitz NL, Hall S, Bonas T, Hall SM.

Health Psychol. 2014 Dec;33(12):1518-29. doi: 10.1037/a0035164. Epub 2014 Jan 27.


Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison.

Gagne JJ, Bykov K, Choudhry NK, Toomey TJ, Connolly JG, Avorn J.

BMJ. 2013 Sep 17;347:f5307. doi: 10.1136/bmj.f5307.


The role of academic pharmacy in tobacco cessation and control.

McBane SE, Corelli RL, Albano CB, Conry JM, Della Paolera MA, Kennedy AK, Jenkins AT, Hudmon KS.

Am J Pharm Educ. 2013 Jun 12;77(5):93. doi: 10.5688/ajpe77593.


The next therapeutic challenge in HIV: polypharmacy.

Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC.

Drugs Aging. 2013 Aug;30(8):613-28. doi: 10.1007/s40266-013-0093-9. Review.


Metabolism of the environmental toxicant benzo(a)pyrene by subcellular fractions of human ovary.

Rekhadevi PV, Diggs DL, Huderson AC, Harris KL, Archibong AE, Ramesh A.

Hum Exp Toxicol. 2014 Feb;33(2):196-202. doi: 10.1177/0960327113489050. Epub 2013 May 23.


It's not that simple: tobacco use identification and documentation in acute care.

Smith PM, Cobb N, Corso L.

Int J Environ Res Public Health. 2013 May 21;10(5):2069-83. doi: 10.3390/ijerph10052069.


Prediction of drug response and safety in clinical practice.

Monte AA, Heard KJ, Vasiliou V.

J Med Toxicol. 2012 Mar;8(1):43-51. doi: 10.1007/s13181-011-0198-7.


A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Dodd S, Malhi GS, Tiller J, Schweitzer I, Hickie I, Khoo JP, Bassett DL, Lyndon B, Mitchell PB, Parker G, Fitzgerald PB, Udina M, Singh A, Moylan S, Giorlando F, Doughty C, Davey CG, Theodoros M, Berk M.

Aust N Z J Psychiatry. 2011 Sep;45(9):712-25. doi: 10.3109/00048674.2011.595686. Review.


Adverse effects of smoking on patients with ocular inflammation.

Galor A, Feuer W, Kempen JH, Kaçmaz RO, Liesegang TL, Suhler EB, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Thorne JE.

Br J Ophthalmol. 2010 Jul;94(7):848-53. doi: 10.1136/bjo.2009.174466.


Clinical pharmacology in the adolescent oncology patient.

Veal GJ, Hartford CM, Stewart CF.

J Clin Oncol. 2010 Nov 10;28(32):4790-9. doi: 10.1200/JCO.2010.28.3473. Epub 2010 May 3. Review.


Smoking, clopidogrel, and mortality in patients with established cardiovascular disease.

Berger JS, Bhatt DL, Steinhubl SR, Shao M, Steg PG, Montalescot G, Hacke W, Fox KA, Lincoff AM, Topol EJ, Berger PB; CHARISMA Investigators.

Circulation. 2009 Dec 8;120(23):2337-44. doi: 10.1161/CIRCULATIONAHA.109.866533. Epub 2009 Nov 23.


Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking.

Jin Y, Pollock BG, Coley K, Miller D, Marder SR, Florian J, Schneider L, Lieberman J, Kirshner M, Bies RR.

J Clin Pharmacol. 2010 Jan;50(1):73-80. doi: 10.1177/0091270009343694. Epub 2009 Oct 20.


Clozapine-induced bowel infarction: a case report.

McKinnon ND, Azad A, Waters BM, Joshi KG.

Psychiatry (Edgmont). 2009 Mar;6(3):30-5.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk